The endocrine system releases chemical messengers known as hormones. These chemical messengers are release by endocrine glands in the body and then these hormones are released in the blood, to be transferred to the target organs in the body. Adding, blocking or removing hormones for treating a disease is known as hormone therapy or Endocrine therapy. This therapy is used for treating diseases like diabetes, postmenopausal symptoms, cancer or many more diseases. Endocrine therapy has an agent which targets the hormone which is responsible for the disease or the organ which is producing that hormone.
Click Here to Get a Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/5193
Global endocrine therapy drugs (ETDs) market is forecast to be valued at US$ 28,958.4 Mn in 2022 during the forecast period.
Impact of COVID-19:
SARS-CoV-2 was reported from China in December 2019, and the World Health Organization announced it as a pandemic in March 2020. The Weekly Epidemiological Update by the WHO on COVID-19 stated that the infection has been transmitted to almost 392 million individuals and has caused the death of 5.7 million individuals until January 30, 2022. The pandemic had a negative impact on the healthcare sector as it affected the supply chains. However, it is estimated that the pandemic might have a positive impact on the endocrine therapy drugs (ETDs) market, due to increasing adoption of endocrine therapy for delaying surgeries in breast cancer patients during the pandemic. For instance, the Breast Cancer Research and Treatment journal published an article in March 2021, mentioning that a survey was conducted amongst radiation oncologists, surgeons and medical oncologists carrying out several clinical trials in the U.S. from May-June, in 2020. It was concluded from the survey that before the pandemic, almost 46% of respondents used neoadjuvant endocrine therapy for deferral of surgery rarely, however, during the pandemic majority of physicians preferred to use NET and also recommended omission of axillary lymph node dissection surgery after using Net for 1-3 months.
Rising incidences of chronic diseases like diabetes, cancer and many others is estimated to augment growth of the global endocrine therapy drugs (ETDs) market during the forecast period. For instance, the American Cancer Society published their data in January 2022, which mentioned that in the U.S. more than 3.8 million women have certain history of breast cancer, it also mentioned that the rate of prevalence of breast cancer is increasing by 0.5% every year.
Rising research and developmental activities for the developing endocrine therapy drugs (ETDs) for diseases like breast cancer, diabetes and several others is estimated to boost growth of the global endocrine therapy drugs (ETDs) market growth during the forecast period. For instance, Eli Lilly and Company started phase 3 clinical trials of imlunestrant. These clinical trials are determining the efficacy of the drug and they are expected to complete until September 2026. For instance, Myovant Sciences GmbH and Pfizer Inc., declared that they have gained approval from the U.S. FDA, in April 2021, for their supplement new drug application MYFEMBREE, this drug helps in pain management related to endometriosis.
Increasing side effects related to the usage of endocrine therapy drugs (ETDs) is estimated to hamper growth of the global endocrine therapy drugs (ETDs) market during the forecast period. For instance, the National Cancer Institute published their data in July 2021, mentioned that night sweats, mood swings, loss of libido, hot flashes and vaginal dryness are some of the side effects of endocrine therapy drugs.
By Drug Type:
- Anti-diabetic Drugs
- Anti-osteoporosis Drugs
- Contraceptive Drugs
- Breast Cancer Drugs
- Others (Menopause Drugs, among others)
- Breast Cancer
- Others (Gender Reassignment Surgery, Hypothyroidism, among others)
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- North America
- Latin America
- Asia Pacific
- Middle East
Ask For Discount Before Purchasing This Business Report : https://www.coherentmarketinsights.com/insight/request-discount/5193
Key players active in the global endocrine therapy drugs (ETDs) market are QuatRx Pharmaceuticals, Novo Nordisk A/S, Noven Pharmaceuticals, Inc., AstraZeneca, Amgen Inc., Generex Biotechnology, BioSante Pharmaceuticals, Orion Pharma AB, Allergan, Sanofi, Pfizer Inc., Teva Pharmaceutical Industries Ltd., TherapeuticsMD, Inc., F. Hoffmann-La Roche, Merck & Co., Inc., Hisamitsu Pharmaceutical Co.,Inc., Tonghua Dongbao Pharmaceutical Co., Ltd., Bayer AG, Abbott and Eli Lilly and Company.
Reasons to buy this Endocrine Therapy Drugs (ETDs) Market Report
☑ It attempts an analysis of the competing scenario.
☑ The current and exceptional product revenue market.
☑ An in-depth data on the regional investigation and competitive landscape structure.
☑ It benefits in creating an awareness of the important key product segments.
☑ The marketing strategies, opportunities, and development factors are explained.
☑ Endocrine Therapy Drugs (ETDs) market size estimation and recent advancements in the industry are explained.
The Study Objectives are:
✔ A comprehensive insight into key players operating in the Endocrine Therapy Drugs (ETDs) Market and their corresponding data.
✔ It includes product portfolio, annual revenue, expenditure on research and development, geographical presence, key developments in recent years, and growth strategies.
✔ Regional analysis, which includes insight into the dominant market and corresponding market share.
✔ It also includes various socio-economic factors affecting the evolution of the market in the region.
✔ The report offers a comprehensive insight into different individuals from value chains such as raw materials suppliers, distributors, and stockholders.
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Endocrine Therapy Drugs (ETDs) Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Endocrine Therapy Drugs (ETDs) Industry Impact
Chapter 2 Global Endocrine Therapy Drugs (ETDs) Competition by Types, Applications, and Top Regions and Countries
2.1 Global Endocrine Therapy Drugs (ETDs) (Volume and Value) by Type
2.3 Global Endocrine Therapy Drugs (ETDs) (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Endocrine Therapy Drugs (ETDs) Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 North America Endocrine Therapy Drugs (ETDs) Market Analysis
Chapter 6 East Asia Endocrine Therapy Drugs (ETDs) Market Analysis
Chapter 7 Europe Endocrine Therapy Drugs (ETDs) Market Analysis
Chapter 8 South Asia Endocrine Therapy Drugs (ETDs) Market Analysis
Chapter 9 Southeast Asia Endocrine Therapy Drugs (ETDs) Market Analysis
Chapter 10 Middle East Endocrine Therapy Drugs (ETDs) Market Analysis
Chapter 11 Africa Endocrine Therapy Drugs (ETDs) Market Analysis
Chapter 12 Oceania Endocrine Therapy Drugs (ETDs) Market Analysis
Chapter 13 South America Endocrine Therapy Drugs (ETDs) Market Analysis
Chapter 14 Company Profiles and Key Figures in Endocrine Therapy Drugs (ETDs) Business
Chapter 15 Global Endocrine Therapy Drugs (ETDs) Market Forecast (2022-2028)
Chapter 16 Conclusions
Buy This Complete Business Report @ https://www.coherentmarketinsights.com/insight/buy-now/5193
Customization of the Report
Our research analysts will help you to get customized details for your report, which can be modified in terms of a specific region, application or any statistical details. In addition, we are always willing to comply with the study, which triangulated with your own data to make the market research more comprehensive in your perspective.
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027